NASDAQ: TGTX
Tg Therapeutics Inc Stock Ownership - Who owns Tg Therapeutics?

Insider buying vs selling

Have Tg Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yann EchelardDirector2025-11-245,000$32.57
$162.85kSell
Sagar LonialDirector2025-09-1120,852$32.24
$672.27kSell

1 of 1

TGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TGTX insiders and whales buy or sell their stock.

TGTX Shareholders

What type of owners hold Tg Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael S. Weiss22.06%33,760,975$1.68BInsider
Blackrock Inc14.54%22,252,930$1.11BInstitution
Ra Capital Management LP8.25%12,629,868$628.46MInsider
Lindsay A. Md Rosenwald6.18%9,462,616$470.86MInsider
State Street Corp5.65%8,649,766$430.41MInstitution
Vanguard Portfolio Management LLC5.41%8,273,979$411.71MInstitution
Biotechnologies Sasu Lfb4.97%7,614,855$378.92MInsider
Vanguard Capital Management LLC4.31%6,603,258$328.58MInstitution
Soleus Capital Management LP2.63%4,029,319$200.50MInstitution
Joan Pons Gimbert2.59%3,959,149$197.01MInsider

1 of 3

TGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TGTX58.60%41.40%Net Selling
RYTM88.71%11.29%Net SellingNet Buying
COGT93.06%6.94%Net Selling
LQDA47.10%52.90%Net SellingNet Selling
IBRX16.79%7.21%Net BuyingNet Selling

Tg Therapeutics Stock Ownership FAQ

Who owns Tg Therapeutics?

Tg Therapeutics (NASDAQ: TGTX) is owned by 68.85% institutional shareholders, 48.65% Tg Therapeutics insiders, and 0.00% retail investors. Michael S. Weiss is the largest individual Tg Therapeutics shareholder, owning 33.76M shares representing 22.06% of the company. Michael S. Weiss's Tg Therapeutics shares are currently valued at $1.68B.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.